AVAI BIO, INC.
AVAI · OTCMCIK 1740797fmd_1HK82KZXWJYQYDENT7E04RQ531Services · Services-Computer Processing & Data PreparationTemplate: Standard
Coverage: Apr 01, 2018 to Jun 30, 2026, 33 periods
Latest annual · FY2023
Millions- Total revenues
- 0
- Gross profit
- (0)
- Operating income
- (2)
- Net income
- (2)
Latest quarter · Q1 FY2027
Millions- Operating income
- (1)
- Net income
- (1)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2021 to FY2023
- n/m
- Net income, 5 yearsFY2021 to FY2026
- n/m
AVAI BIO, INC. (AVAI) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2026 | FY2025 | Change | Source |
|---|---|---|---|---|
| Operating income | -$1.7 million | -$1.1 million | 10-K 2026-07-14 · proof | |
| Net income | -$1.7 million | -$1.1 million | 10-K 2026-07-14 · proof | |
| Cash from operating activities | -$1 million | -$1.2 million | 10-K 2026-07-14 · proof | |
| Total assets | $572,696 | $224,745 | +154.8% | 10-K 2026-07-14 · proof |
| Total liabilities | $3.4 million | $1.8 million | +89.4% | 10-K 2026-07-14 · proof |
| Cash and cash equivalents | $23,145 | $81,053 | -71.4% | 10-K 2026-07-14 · proof |
- What was AVAI BIO, INC. (AVAI)'s operating income in fiscal 2026?
- AVAI BIO, INC. (AVAI) reported operating income of -$1.7 million for fiscal 2026 (the year ended Mar 31, 2026), against -$1.1 million the year before. Source: the 10-K filed with the SEC on Jul 14, 2026. SEC
- What was AVAI BIO, INC. (AVAI)'s net income in fiscal 2026?
- AVAI BIO, INC. (AVAI) reported net income of -$1.7 million for fiscal 2026 (the year ended Mar 31, 2026), against -$1.1 million the year before. Source: the 10-K filed with the SEC on Jul 14, 2026. SEC
- What was AVAI BIO, INC. (AVAI)'s cash from operating activities in fiscal 2026?
- AVAI BIO, INC. (AVAI) reported cash from operating activities of -$1 million for fiscal 2026 (the year ended Mar 31, 2026), against -$1.2 million the year before. Source: the 10-K filed with the SEC on Jul 14, 2026. SEC
- What are AVAI BIO, INC. (AVAI)'s total assets?
- As of Mar 31, 2026, AVAI BIO, INC. (AVAI) reported total assets of $572,696, against $224,745 a year earlier (+154.8%). Source: the 10-K filed with the SEC on Jul 14, 2026. SEC
- What are AVAI BIO, INC. (AVAI)'s total liabilities?
- As of Mar 31, 2026, AVAI BIO, INC. (AVAI) reported total liabilities of $3.4 million, against $1.8 million a year earlier (+89.4%). Source: the 10-K filed with the SEC on Jul 14, 2026. SEC
- What are AVAI BIO, INC. (AVAI)'s cash and cash equivalents?
- As of Mar 31, 2026, AVAI BIO, INC. (AVAI) reported cash and cash equivalents of $23,145, against $81,053 a year earlier (-71.4%). Source: the 10-K filed with the SEC on Jul 14, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:AVAI&period_type=annual&limit=5"Information only, not investment advice.